The Food and Drug Administration (FDA) is a federal agency responsible for protecting the public health through the regulation and supervision of a variety of areas, such as our nation’s food supply, tobacco products, vaccines, and cosmetics.
Most notably for the Parkinson’s community, FDA is responsible for evaluating new drugs and medical devices before they can be sold. Before any medical product can be made publicly available, it must first go through a rigorous review and approval process by the FDA.
PAN supports the work of the FDA through two primary issue areas: federal funding and legislation and regulations.
PAN advocates for adequate federal funding for the FDA in order to hasten the approval of much-needed new treatments and a cure for Parkinson’s disease. In Fiscal Year (FY) 2014, the FDA was seen as a priority and given an increase to restore funding lost to sequestration. Learn more.
Legislation and Regulations
Recognizing the urgent need for breakthrough therapies for Parkinson’s disease, PAN strongly supports efforts to ensure FDA has at its disposal the necessary tools and resources to hasten the availability of new treatments for Parkinson’s and other chronic diseases. PAN actively monitors and, when appropriate, comments on, legislative and regulatory measures aimed to further this goal. Learn more.